Home Merck Raises 2013 Profit Forecast on Progress in Cost Cuts
 

Keywords :   


Merck Raises 2013 Profit Forecast on Progress in Cost Cuts

2013-11-15 02:03:46| Biotech - Topix.net

Merck KGaA, the German maker of the cancer drug Erbitux, raised its profit forecast for the year as cost reductions are taking effect faster than planned.

Tags: cost progress profit cuts

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
05.10Tropical Depression Fourteen Graphics
05.10Tropical Depression Fourteen Forecast Discussion Number 1
05.10Tropical Depression Fourteen Wind Speed Probabilities Number 1
05.10Tropical Depression Fourteen Public Advisory Number 1
05.10Summary for Tropical Depression Fourteen (AT4/AL142024)
05.10Tropical Depression Fourteen Forecast Advisory Number 1
05.10Hurricane Kirk Graphics
05.10Hurricane Kirk Forecast Discussion Number 25
More »